Acid Suppression for Gastroesophageal Reflux Disease in Infants

Area of Science:

• Pediatrics
• Gastroenterology

Background:

• Gastroesophageal reflux is a common, typically self-resolving condition in infants.
• Gastroesophageal reflux disease (GERD) develops infrequently, necessitating potential interventions.
• Current interventions for infant GERD vary in invasiveness and evidence base.

Purpose of the Study:

• To review the current landscape of interventions for infant GERD.
• To highlight the limitations in efficacy and safety data for pharmacologic and surgical approaches.
• To emphasize the importance of cautious utilization and monitoring of therapies.

Main Methods:

• Literature review on nonpharmacologic, pharmacologic, and surgical interventions for infant GERD.
• Analysis of available efficacy and safety data for different treatment modalities.
• Discussion of risks associated with pharmacologic treatments, particularly in younger infants.

Main Results:

• Nonpharmacologic interventions are considered first-line therapy for infant GERD.
• Pharmacologic and surgical treatments for infant GERD are controversial due to limited efficacy data and potential safety concerns.
• Serious risks associated with medications, especially in younger infants, necessitate cautious application.

Conclusions:

• Infant GERD management should prioritize nonpharmacologic approaches.
• Pharmacologic interventions for infant GERD require careful consideration of risks versus benefits.
• A rigorous monitoring plan is crucial for optimizing outcomes and minimizing adverse events in infant GERD treatment.